Myrrh mouthwash use after teeth extraction
ISRCTN | ISRCTN82716015 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN82716015 |
Secondary identifying numbers | E-17-2609 |
- Submission date
- 16/04/2019
- Registration date
- 19/04/2019
- Last edited
- 22/01/2021
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Oral Health
Plain English Summary
Background and study aims
The early period after tooth extraction is a critical period for wound healing. Wounds usually heal normally unless interfered with factors either local or systemic. In certain circumstances the early wound healing can be improved by interventions such as antibiotics, mouthwashes, or topical medicine applications. The aim of this study is to investigate the effect of myrrh mouthwash on wound healing during the early period after tooth extraction.
Who can participate?
Physically healthy adult patients referred for simple tooth extraction
What does the study involve?
Participants are assessed and their tooth is extracted under local anaesthetic in the standard manner. They then receive a medication to be used twice a day starting from the second day after surgery. Selection of the material to be used as a mouthwash is by chance. Participants in one group are given the test medication mouthwash while participants of the other group are given a placebo (dummy) mouthwash. The medication is given in a plastic pack to take home, dispense its contents in a cup of warm water, and rinse their mouth thoroughly with half of the cup in the morning and another half at bedtime. Participants do this daily until the seventh day after surgery. Participants are seen in the clinic for follow up on the seventh day. During the follow up the wound healing process is assessed and oral x-rays may be taken according to the clinical need. The examination follow up appointment takes 20 minutes using routine examination instruments.
What are the possible benefits and risks of participating?
Participants may have better wound healing if they are using the mouthwash. However, this can’t be guaranteed. Others may benefit in the future from the results of this study. There are no known risks of using the mouthwash.
Where is the study run from?
King Saud University, Riyadh, KSA
When is the study starting and how long is it expected to run for?
November 2017 to March 2019
Who is funding the study?
Funded by the researcher
Who is the main contact?
Dr Raniah Al Eid
dr.raniahaleid@hotmail.com
Contact information
Scientific
Al Sulaimaniyah
King Abdulaziz Street
Al Riyadh
Riyadh
11314
Saudi Arabia
Phone | +966 (0)500850350 |
---|---|
dr.raniahaleid@hotmail.com |
Study information
Study design | Randomized double-blind placebo control based study |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Prevention |
Participant information sheet | Not available in web format, contact details: +966 (0)500850350 |
Scientific title | Efficacy of Commiphora myrrh mouthwash on the early wound healing after tooth extraction: a randomized controlled trial |
Study hypothesis | To prove the healing potentiation effect of myrrh mouthwash during the early post extraction period. |
Ethics approval(s) | Approved 30/11/2017, Institutional Review Board (IRB) in King Saud University (College of Medicine, KSU; Tel.: (1) 469 1531, (1) 469 1532; Email: balferez@ksu.edu.sa; irb.medksu@hotmail.com), ref: E-17-2609 |
Condition | Tooth extraction |
Intervention | 40 healthy adult patients were included in the study. Estimating sample size for a randomized controlled trial (using EPI Info 7, StatCalc, CDC, USA), assuming 95% confidence level and statistical power of 90%, the sample size was estimated as 36 patients (18 cases + 18 controls). After allowing 10% overestimation for any loss due to following up, the final sample size was calculated as 40 patients (20 cases + 20 controls). The procedure was performed in a randomized double-blind placebo control based study in which both the participants and the examiner were masked. Subjects were assigned at random to the exposure and the control and only the dental assistant knows them. All participants underwent dental extraction under local anaesthesia at Oral and Maxillofacial Surgery Clinic, College of Dentistry, King Saud University. Standard pre-operative and post-operative extraction protocols adhered. All patients were advised to have good oral hygiene postoperatively. Patients were randomized into two groups: Group A (test group) were prescribed to use Commiphora molmol (myrrh) extract as a mouthwash twice daily for 7 days beginning from the 1st postoperative day. The myrrh was prepared by the researcher in a form of mouthwash of a 1:5 @ 90% of myrrh . The researcher provided the myrrh commercially, then it was ground and packed in unlabelled white filter paper packs. Patients were instructed to put each pack in a cup of warm water for use as a mouthwash. Group B (control group) were prescribed to use saline mouthwash twice daily for 7 days beginning from the 1st postoperative day. The saline was prepared by the researcher in which each pack contains 9 grams of sodium chloride (NaCl). Similarly, patients were instructed to put each pack in a cup of warm water for use as a mouthwash. All packs used for both groups were the same: white filter paper. Randomization of the patients was double-blinded to the clinician and the participant and was documented only by a neutral dental assistant. In order to eliminate bias each one of the mouthwash pack was labelled with a code number according to the randomization sequence. The post-operative assessment was performed on the 7th day. It included a recording of patients' symptoms, systemic and local findings. The local findings included the presence/absence of swelling or facial asymmetry, examination of the oral condition including colour of the gingiva around the extracted socket, presence of any signs of infection as pain, tenderness, abnormal odour, pus discharge, bleeding, socket size, loss of function such as limited mouth opening or numbness and any other findings. |
Intervention type | Other |
Primary outcome measure | Patients' symptoms, systemic and local findings. The local findings included the presence/absence of swelling or facial asymmetry, examination of the oral condition including colour of the gingiva around the extracted socket, presence of any signs of infection such as pain (measured using Visual Analogue Scale), tenderness, abnormal odour, pus discharge, bleeding, socket size, loss of function such as limited mouth opening (using a calibrated digital caliper) or numbness, and any other findings. A single examiner performed all clinical measurements prior to surgery (baseline) as well as on the 7th day in the postoperative period. |
Secondary outcome measures | There are no secondary outcome measures |
Overall study start date | 30/11/2017 |
Overall study end date | 16/03/2019 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Lower age limit | 18 Years |
Upper age limit | 45 Years |
Sex | Both |
Target number of participants | 40 participants |
Total final enrolment | 40 |
Participant inclusion criteria | 1, Young adults in the age range of 18-45 years old ASA I adults 2. The tooth that is indicated for extraction is not infected 3. Absence of any pathology in the area of the tooth for extraction and neighbouring teeth 4. Teeth that require simple extraction 5. The patient should accept to participate in the study and sign a consent emphasizing his/her understanding of all possible risks, the aim and methodology of the study |
Participant exclusion criteria | 1. Medically compromised patients 2. Pregnant females 3. Teeth that require surgical extractions 4. Teeth related to abscess or pathology |
Recruitment start date | 16/09/2018 |
Recruitment end date | 16/03/2019 |
Locations
Countries of recruitment
- Saudi Arabia
Study participating centre
Riyadh
11314
Saudi Arabia
Sponsor information
Hospital/treatment centre
PO Box 7805
Al Riyadh
Riyadh
11472
Saudi Arabia
Phone | +966 (0)114691532 |
---|---|
irb.medksu@hotmail.com | |
https://ror.org/046gga527 |
Funders
Funder type
Other
No information available
Results and Publications
Intention to publish date | 18/07/2019 |
---|---|
Individual participant data (IPD) Intention to share | Yes |
IPD sharing plan summary | Available on request |
Publication and dissemination plan | Planned publication in International Dental Journal as soon as possible immediately following trial registration. |
IPD sharing plan | The datasets generated during and/or analysed during the current study are/will be available upon request from Dr Raniah Al Eid (dr.raniahaleid@hotmail.com). Patient's confidentiality is maintained and data doesn't include any personal information nor pictures. The data included results of clinical assessment and referred to by codes instead of names. The data is analyzed statistically using SPSS, descriptive statistics and Mann-Whitney Wilcoxon test. All participants have signed the informed consent after understanding the study and agreed to participate. The data can be submitted for the reviewers if requested for the sake of scientific review and not for publication. |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | results | 01/01/2021 | 22/01/2021 | Yes | No |
Editorial Notes
22/01/2021: Publication reference and total final enrolment added.
18/04/2019: Trial's existence confirmed by Institutional Review Board (IRB) in King Saud University.